Agenus
AGEN
#9256
Rank
โ‚ฌ86.58 M
Marketcap
2,40ย โ‚ฌ
Share price
-5.02%
Change (1 day)
-35.39%
Change (1 year)

Revenue for Agenus (AGEN)

Revenue in 2025 (TTM): โ‚ฌ95.59 Million

According to Agenus 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ90.12 Million. In 2024 the company made a revenue of โ‚ฌ99.42 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ0.14 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agenus from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ95.59 M-3.85%
2024 โ‚ฌ99.42 M-29.69%
2023 โ‚ฌ0.14 B54.73%
2022 โ‚ฌ91.38 M-65%
2021 โ‚ฌ0.26 B264.2%
2020 โ‚ฌ71.68 M-46.48%
2019 โ‚ฌ0.13 B316.57%
2018 โ‚ฌ32.15 M-10.02%
2017 โ‚ฌ35.73 M66.52%
2016 โ‚ฌ21.46 M-5.45%
2015 โ‚ฌ22.69 M295.62%
2014 โ‚ฌ5.73 M160.18%
2013 โ‚ฌ2.2 M-81.73%
2012 โ‚ฌ12.06 M468.61%
2011 โ‚ฌ2.12 M-15.99%
2010 โ‚ฌ2.52 M8.53%
2009 โ‚ฌ2.32 M22.73%
2008 โ‚ฌ1.89 M-50.13%
2007 โ‚ฌ3.8 M624.95%
2006 โ‚ฌ0.52 M-1.37%
2005 โ‚ฌ0.53 M2.03%
2004 โ‚ฌ0.52 M-81.4%
2003 โ‚ฌ2.8 M-14.14%
2002 โ‚ฌ3.26 M-36.73%
2001 โ‚ฌ5.15 M997.72%
2000 โ‚ฌ0.46 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ77.73 B 86,158.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ54.18 B 60,028.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ40.52 B 44,863.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ35.72 B 39,545.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚ฌ2.19 M-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA